Two Fifth-Generation Fighter Pilots Discovered with Latent Autoimmune Diabetes.

Area of Science:

• Aerospace Medicine
• Endocrinology
• Immunology

Background:

• Fighter pilots undergo rigorous medical evaluations, yet rare conditions like Latent Autoimmune Diabetes in Adults (LADA) may be missed.
• LADA is characterized by autoantibodies targeting pancreatic beta cells, leading to late-onset diabetes that can evade standard military flight screenings.

Observation:

• Two fighter pilots, aged 38 and 27, presented with fatigue, weight loss, polyuria, and arthralgia, initially misattributed to other causes.
• Diagnostic workups revealed elevated HbA1C, positive GAD-65, anti-TPO, anti-islet cell, and ZnT8 antibodies, confirming LADA in both cases.

Findings:

• Both pilots required insulin therapy initially; one also needed levothyroxine for hypothyroidism and was retired from flying.
• The second pilot transitioned to metformin and returned to flying duties with an aeromedical waiver, highlighting potential management pathways.

Implications:

• Peak physical fitness in pilots may mask LADA symptoms, delaying diagnosis.
• Current USAF regulations restrict insulin use for flying, underscoring the need for early LADA detection.
• Implementing early autoantibody screening during pilot selection could be a cost-effective diagnostic strategy for LADA.